Therapeutic antibodies for improved wound healing

Autor: Turner, CT, McInnes, SJP, Cowin, AJ

Therapeutic monoclonal antibodies (mAbs) are the fastest growing area of drug development, with an increasing number of diseases, including rheumatoid arthritis, multiple sclerosis and various forms of cancer, now amenable to treatment. Therapeutic m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1231::5ead15b77a521941ad1bec87ad9ab83a
https://hdl.handle.net/11541.2/134028

Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery.

Autor: Rabiei M; Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah, Iran., Kashanian S; Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah, Iran.; Faculty of Chemistry, Sensor and Biosensor Research Center (SBRC) and Nanoscience and Nanotechnology Research Center (NNRC), Razi University, Kermanshah, Iran.; Nano Drug Delivery Research Center, Kermanshah University of Medical Science, Kermanshah, Iran., Samavati SS; Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah, Iran., Derakhshankhah H; Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran., Jamasb S; Department of Biomedical Engineering, Hamedan University of Technology, Hamedan, Iran., McInnes SJP; University of South Australia, UniSA STEM, Mawson Lakes, South Australia.

Publikováno v: Journal of drug targeting [J Drug Target] 2022 Mar; Vol. 30 (3), pp. 233-243. Date of Electronic Publication: 2021 Aug 29.

Impact of resveratrol-mediated increase in uterine artery blood flow on fetal haemodynamics, blood pressure and oxygenation in sheep.

Autor: Aujla T; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.; Early Origins of Adult Health Research Group, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Darby JRT; Early Origins of Adult Health Research Group, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.; Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Saini BS; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.; Early Origins of Adult Health Research Group, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Lock MC; Early Origins of Adult Health Research Group, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.; Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Holman SL; Early Origins of Adult Health Research Group, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.; Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Bradshaw EL; Early Origins of Adult Health Research Group, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.; Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Perumal SR; Preclinical Imaging and Research Laboratories, South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia., McInnes SJP; UniSA STEM, University of South Australia, Adelaide, South Australia, Australia., Voelcker NH; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Clayton, Victoria, Australia.; Department of Materials Science and Engineering, Monash University, Clayton, Victoria, Australia., Wiese MD; Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Macgowan CK; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada., Seed M; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada., Morrison JL; Early Origins of Adult Health Research Group, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.; Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.

Publikováno v: Experimental physiology [Exp Physiol] 2021 May; Vol. 106 (5), pp. 1166-1180. Date of Electronic Publication: 2021 Mar 16.

Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.

Autor: Rabiei M; Department of Nanobiotechnology, Razi University, Kermanshah, Iran., Kashanian S; Department of Nanobiotechnology, Razi University, Kermanshah, Iran.; Faculty of Chemistry, Sensor and Biosensor Research Center (SBRC) & Nanoscience and Nanotechnology Research Center (NNRC), Razi University, Kermanshah, Iran.; Nano Drug Delivery Research Center, Kermanshah University of Medical Science, Kermanshah, Iran., Samavati SS; Department of Nanobiotechnology, Razi University, Kermanshah, Iran., Jamasb S; Department of Biomedical Engineering, Hamedan University of Technology, Hamedan, 65169-13733, Iran., McInnes SJP; University of South Australia, Division of Information Technology, Engineering and the Environment, Mawson Lakes, Mawson Lakes 5095, Australia.

Publikováno v: Current pharmaceutical biotechnology [Curr Pharm Biotechnol] 2020; Vol. 21 (5), pp. 374-383.

Porous silicon-poly(ε-caprolactone) film composites: evaluation of drug release and degradation behavior.

Autor: Bodiford NK; Department of Chemistry and Biochemistry, Texas Christian University, Fort Worth, TX, 76129, USA., McInnes SJP; University of South Australia, GPO Box 2471, Adelaide, South Australia, 5001, Australia., Voelcker NH; Victorian Node of the Australian National Fabrication Facility, Melbourne Centre for Nanofabrication, 151 Wellington Road, Clayton, VIC, 3168, Australia.; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, 3168, Australia., Coffer JL; Department of Chemistry and Biochemistry, Texas Christian University, Fort Worth, TX, 76129, USA. j.coffer@tcu.edu.

Publikováno v: Biomedical microdevices [Biomed Microdevices] 2018 Aug 10; Vol. 20 (3), pp. 71. Date of Electronic Publication: 2018 Aug 10.